These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3389490)

  • 1. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG; Moguel A
    Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of a new delayed-action theophylline preparation (1 dose in 24 hours) in the treatment of childhood asthma].
    Ciofetta G; Indinnimeo L; De Castro G; Lo Tesoriere A; Barretta MA; Lalia F; Zicari AM; Ronchetti R
    Minerva Pediatr; 1986 Oct; 38(19):843-8. PubMed ID: 3796546
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of increasing the evening dose of controlled release theophylline in patients with reversible airways obstruction.
    Haig G
    Br J Clin Pract Suppl; 1984; 32():22-4. PubMed ID: 6432020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anhydrous theophylline in micropellets with prolonged action in asthmatic children].
    Massey LF; Escobedo V
    Rev Alerg Mex (1987); 1989; 36(6):245-51. PubMed ID: 2699068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P; Steinijans VW
    Prax Klin Pneumol; 1987 Oct; 41(10):442-4. PubMed ID: 3325964
    [No Abstract]   [Full Text] [Related]  

  • 8. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
    Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualized therapy of protracted attacks of bronchial asthma using theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ VP; Semenova LG; Antonovskiĭ IuA
    Sov Med; 1990; (6):77-81. PubMed ID: 2396131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
    Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
    Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG
    Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic asthma in children with a sustained-release preparation of theophylline in addition to beta 2-stimulating agents.
    Lönnerholm G; Foucard T; Lindström B
    Eur J Respir Dis Suppl; 1980; 109():95-7. PubMed ID: 6108230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged-action theophylline in the treatment of bronchial asthma].
    Ter Arkh; 1989; 61(8):30-7. PubMed ID: 2588163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.